Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NYSE: SOLV) | Delayed: 86.79 +0.12 (0.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $86.67 | 52 Week High | $ | |||
| Open | $86.89 | 52 Week Low | $ | |||
| Day High | $87.87 | P/E | N/A | |||
| Day Low | $86.70 | EPS | $ | |||
| Volume | 250,160 | |||||
